GF Fund Management’s Amicus Therapeutics FOLD Stock Holding History

GF Fund Management’s Portfolio FOLD Stock Details FOLD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-6,929	Closed	-$100K	–	608
2026 Q1	$100K	Buy	6,929 +866	+14%	+$12.4K	﹤0.01%	342
2025 Q4	$86.3K	Sell	6,063 -569	-9%	-$5.59K	﹤0.01%	360
2025 Q3	$52.3K	Sell	6,632 -1,019	-13%	-$7.25K	﹤0.01%	391
2025 Q2	$43.8K	Hold	7,651	–	–	﹤0.01%	430
2025 Q1	$62.4K	Buy	7,651 +1,377	+22%	+$12.7K	﹤0.01%	400
2024 Q4	$59.1K	Buy	+6,274	New	+$65.2K	﹤0.01%	372

Other funds holding FOLD

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

GF Fund Management's FOLD Position: Q2 2026 in Review

GF Fund Management sold out of Amicus Therapeutics (FOLD) in Q2 2026, closing a stake of 6,929 shares — an estimated $100K sold.

GF Fund Management first reported a position in FOLD in Q4 2024 and held it in 6 quarters. The position peaked at $100K in Q1 2026. 2 funds tracked by Wall St. Rank hold FOLD as of Q2 2026.

GF Fund Management reported no remaining Amicus Therapeutics position as of Q2 2026 after selling out during the quarter.
GF Fund Management sold 6,929 Amicus Therapeutics shares in Q2 2026, an estimated $100K.
GF Fund Management first reported a position in Amicus Therapeutics in Q4 2024 and held it in 6 quarters.
GF Fund Management's Amicus Therapeutics position peaked at $100K in Q1 2026.
2 funds tracked by Wall St. Rank held Amicus Therapeutics as of Q2 2026.

Based on GF Fund Management's 13F filing for Q2 2026, filed 7 Aug 2026.